AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From AFX Europe (Focus))
BERKELEY, Calif. (AFX) - Biopharmaceutical company Dynavax Technologies Corp. said Thursday it received an equity financing commitment for up to $30 million over 18 months from Azimuth Opportunity Ltd.
Dynavax may sell registered shares of its newly-issued common stock to Azimuth at a small, pre-negotiated discount to the market price at any time during the …